Loading…

Relationship between LAAM-methadone preference and treatment outcomes

Studies of relative LAAM-methadone preference have indicated that a significant proportion of patients prefer levo-alpha-acetylmethadol (LAAM). The present study was designed to determine whether this preference is associated with better treatment outcomes. Sixty-two stable methadone patients partic...

Full description

Saved in:
Bibliographic Details
Published in:Drug and alcohol dependence 2002-05, Vol.66 (3), p.295-301
Main Authors: WHITE, Jason M, DANZ, Cath, KNEEBONE, Joanne, LA VINCENTE, Sophie F, NEWCOMBE, David A. L, ALI, Robert L
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c366t-3e795846fe706b368722f3cdd092a16c933b4499712da1a3d6f48849efb7a3763
cites cdi_FETCH-LOGICAL-c366t-3e795846fe706b368722f3cdd092a16c933b4499712da1a3d6f48849efb7a3763
container_end_page 301
container_issue 3
container_start_page 295
container_title Drug and alcohol dependence
container_volume 66
creator WHITE, Jason M
DANZ, Cath
KNEEBONE, Joanne
LA VINCENTE, Sophie F
NEWCOMBE, David A. L
ALI, Robert L
description Studies of relative LAAM-methadone preference have indicated that a significant proportion of patients prefer levo-alpha-acetylmethadol (LAAM). The present study was designed to determine whether this preference is associated with better treatment outcomes. Sixty-two stable methadone patients participated in a randomised crossover clinical trial. They received LAAM (alternate days) and methadone (daily) for 3 months each, followed by a further 6-month period during which they were free to choose between the drugs. LAAM maintenance was associated with a lower rate of heroin use than methadone maintenance based on analysis of morphine concentration in hair and equivalent health outcomes. The majority of subjects showed a preference for LAAM (n=27, 69.2%) rather than methadone (n=12, 30.8%). The main reasons given for the LAAM preference were that it produced less withdrawal (39.3%), fewer side effects (28.5%), less craving for heroin (17.9%), and entailed fewer pick-up days (14.3%). Those who chose LAAM had lower levels of heroin use during LAAM maintenance, significantly better outcomes on two sub-scales of the SF-36 (Vitality and Mental Health), and reported that they felt more normal and that they were 'held' better when on LAAM. For those who chose methadone, there were no differences in outcomes between the LAAM and methadone maintenance periods. Preference for LAAM is associated with treatment outcomes as good or better than those with methadone.
doi_str_mv 10.1016/S0376-8716(02)00007-8
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_57857503</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>57857503</sourcerecordid><originalsourceid>FETCH-LOGICAL-c366t-3e795846fe706b368722f3cdd092a16c933b4499712da1a3d6f48849efb7a3763</originalsourceid><addsrcrecordid>eNpFkMlOwzAQhi0EoqXwCKBcQHAIeEm8HKuqLFIREsvZcpyJGpQ4JXaEeHvcNoK5zOX7Z_kQOif4lmDC794wEzyVgvBrTG9wLJHKAzQlUqgU44wfoukfMkEn3n9uIa7wMZoQijnNeDZFy1doTKg759f1JikgfAO4ZDWfP6cthLUpOwfJpocKenAWEuPKJPRgQgsuJN0QbNeCP0VHlWk8nI19hj7ul--Lx3T18vC0mK9SyzgPKQOhcpnxCgTmBeNSUFoxW5ZYUUO4VYwVWaaUILQ0xLCSV5mUmYKqECb-wmboaj9303dfA_ig29pbaBrjoBu8zoXMRY5ZBPM9aPvO-3i-3vR1a_ofTbDe-tM7f3orR2Oqd_60jLmLccFQtFD-p0ZhEbgcAeOtaareOFv7f47xODYe8AsAc3eB</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>57857503</pqid></control><display><type>article</type><title>Relationship between LAAM-methadone preference and treatment outcomes</title><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>ScienceDirect Freedom Collection 2022-2024</source><source>ScienceDirect®</source><creator>WHITE, Jason M ; DANZ, Cath ; KNEEBONE, Joanne ; LA VINCENTE, Sophie F ; NEWCOMBE, David A. L ; ALI, Robert L</creator><creatorcontrib>WHITE, Jason M ; DANZ, Cath ; KNEEBONE, Joanne ; LA VINCENTE, Sophie F ; NEWCOMBE, David A. L ; ALI, Robert L</creatorcontrib><description>Studies of relative LAAM-methadone preference have indicated that a significant proportion of patients prefer levo-alpha-acetylmethadol (LAAM). The present study was designed to determine whether this preference is associated with better treatment outcomes. Sixty-two stable methadone patients participated in a randomised crossover clinical trial. They received LAAM (alternate days) and methadone (daily) for 3 months each, followed by a further 6-month period during which they were free to choose between the drugs. LAAM maintenance was associated with a lower rate of heroin use than methadone maintenance based on analysis of morphine concentration in hair and equivalent health outcomes. The majority of subjects showed a preference for LAAM (n=27, 69.2%) rather than methadone (n=12, 30.8%). The main reasons given for the LAAM preference were that it produced less withdrawal (39.3%), fewer side effects (28.5%), less craving for heroin (17.9%), and entailed fewer pick-up days (14.3%). Those who chose LAAM had lower levels of heroin use during LAAM maintenance, significantly better outcomes on two sub-scales of the SF-36 (Vitality and Mental Health), and reported that they felt more normal and that they were 'held' better when on LAAM. For those who chose methadone, there were no differences in outcomes between the LAAM and methadone maintenance periods. Preference for LAAM is associated with treatment outcomes as good or better than those with methadone.</description><identifier>ISSN: 0376-8716</identifier><identifier>EISSN: 1879-0046</identifier><identifier>DOI: 10.1016/S0376-8716(02)00007-8</identifier><identifier>PMID: 12062464</identifier><identifier>CODEN: DADEDV</identifier><language>eng</language><publisher>Shannon: Elsevier Science</publisher><subject>Adult ; Australia ; Biological and medical sciences ; Chi-Square Distribution ; Cross-Over Studies ; Drug addictions ; Drug addicts ; Female ; Heroin ; Heroin Dependence - drug therapy ; Heroin Dependence - rehabilitation ; Humans ; Levo-alpha-acetylmethadol ; Male ; Medical sciences ; Methadone ; Methadone - therapeutic use ; Methadyl Acetate - therapeutic use ; Middle Aged ; Narcotics - therapeutic use ; Outcomes ; Patient Satisfaction - statistics &amp; numerical data ; Preferences ; Statistics, Nonparametric ; Toxicology ; Treatment ; Treatment Outcome</subject><ispartof>Drug and alcohol dependence, 2002-05, Vol.66 (3), p.295-301</ispartof><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c366t-3e795846fe706b368722f3cdd092a16c933b4499712da1a3d6f48849efb7a3763</citedby><cites>FETCH-LOGICAL-c366t-3e795846fe706b368722f3cdd092a16c933b4499712da1a3d6f48849efb7a3763</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924,30999</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13637603$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12062464$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>WHITE, Jason M</creatorcontrib><creatorcontrib>DANZ, Cath</creatorcontrib><creatorcontrib>KNEEBONE, Joanne</creatorcontrib><creatorcontrib>LA VINCENTE, Sophie F</creatorcontrib><creatorcontrib>NEWCOMBE, David A. L</creatorcontrib><creatorcontrib>ALI, Robert L</creatorcontrib><title>Relationship between LAAM-methadone preference and treatment outcomes</title><title>Drug and alcohol dependence</title><addtitle>Drug Alcohol Depend</addtitle><description>Studies of relative LAAM-methadone preference have indicated that a significant proportion of patients prefer levo-alpha-acetylmethadol (LAAM). The present study was designed to determine whether this preference is associated with better treatment outcomes. Sixty-two stable methadone patients participated in a randomised crossover clinical trial. They received LAAM (alternate days) and methadone (daily) for 3 months each, followed by a further 6-month period during which they were free to choose between the drugs. LAAM maintenance was associated with a lower rate of heroin use than methadone maintenance based on analysis of morphine concentration in hair and equivalent health outcomes. The majority of subjects showed a preference for LAAM (n=27, 69.2%) rather than methadone (n=12, 30.8%). The main reasons given for the LAAM preference were that it produced less withdrawal (39.3%), fewer side effects (28.5%), less craving for heroin (17.9%), and entailed fewer pick-up days (14.3%). Those who chose LAAM had lower levels of heroin use during LAAM maintenance, significantly better outcomes on two sub-scales of the SF-36 (Vitality and Mental Health), and reported that they felt more normal and that they were 'held' better when on LAAM. For those who chose methadone, there were no differences in outcomes between the LAAM and methadone maintenance periods. Preference for LAAM is associated with treatment outcomes as good or better than those with methadone.</description><subject>Adult</subject><subject>Australia</subject><subject>Biological and medical sciences</subject><subject>Chi-Square Distribution</subject><subject>Cross-Over Studies</subject><subject>Drug addictions</subject><subject>Drug addicts</subject><subject>Female</subject><subject>Heroin</subject><subject>Heroin Dependence - drug therapy</subject><subject>Heroin Dependence - rehabilitation</subject><subject>Humans</subject><subject>Levo-alpha-acetylmethadol</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methadone</subject><subject>Methadone - therapeutic use</subject><subject>Methadyl Acetate - therapeutic use</subject><subject>Middle Aged</subject><subject>Narcotics - therapeutic use</subject><subject>Outcomes</subject><subject>Patient Satisfaction - statistics &amp; numerical data</subject><subject>Preferences</subject><subject>Statistics, Nonparametric</subject><subject>Toxicology</subject><subject>Treatment</subject><subject>Treatment Outcome</subject><issn>0376-8716</issn><issn>1879-0046</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><recordid>eNpFkMlOwzAQhi0EoqXwCKBcQHAIeEm8HKuqLFIREsvZcpyJGpQ4JXaEeHvcNoK5zOX7Z_kQOif4lmDC794wEzyVgvBrTG9wLJHKAzQlUqgU44wfoukfMkEn3n9uIa7wMZoQijnNeDZFy1doTKg759f1JikgfAO4ZDWfP6cthLUpOwfJpocKenAWEuPKJPRgQgsuJN0QbNeCP0VHlWk8nI19hj7ul--Lx3T18vC0mK9SyzgPKQOhcpnxCgTmBeNSUFoxW5ZYUUO4VYwVWaaUILQ0xLCSV5mUmYKqECb-wmboaj9303dfA_ig29pbaBrjoBu8zoXMRY5ZBPM9aPvO-3i-3vR1a_ofTbDe-tM7f3orR2Oqd_60jLmLccFQtFD-p0ZhEbgcAeOtaareOFv7f47xODYe8AsAc3eB</recordid><startdate>20020501</startdate><enddate>20020501</enddate><creator>WHITE, Jason M</creator><creator>DANZ, Cath</creator><creator>KNEEBONE, Joanne</creator><creator>LA VINCENTE, Sophie F</creator><creator>NEWCOMBE, David A. L</creator><creator>ALI, Robert L</creator><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope></search><sort><creationdate>20020501</creationdate><title>Relationship between LAAM-methadone preference and treatment outcomes</title><author>WHITE, Jason M ; DANZ, Cath ; KNEEBONE, Joanne ; LA VINCENTE, Sophie F ; NEWCOMBE, David A. L ; ALI, Robert L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c366t-3e795846fe706b368722f3cdd092a16c933b4499712da1a3d6f48849efb7a3763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Australia</topic><topic>Biological and medical sciences</topic><topic>Chi-Square Distribution</topic><topic>Cross-Over Studies</topic><topic>Drug addictions</topic><topic>Drug addicts</topic><topic>Female</topic><topic>Heroin</topic><topic>Heroin Dependence - drug therapy</topic><topic>Heroin Dependence - rehabilitation</topic><topic>Humans</topic><topic>Levo-alpha-acetylmethadol</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methadone</topic><topic>Methadone - therapeutic use</topic><topic>Methadyl Acetate - therapeutic use</topic><topic>Middle Aged</topic><topic>Narcotics - therapeutic use</topic><topic>Outcomes</topic><topic>Patient Satisfaction - statistics &amp; numerical data</topic><topic>Preferences</topic><topic>Statistics, Nonparametric</topic><topic>Toxicology</topic><topic>Treatment</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>WHITE, Jason M</creatorcontrib><creatorcontrib>DANZ, Cath</creatorcontrib><creatorcontrib>KNEEBONE, Joanne</creatorcontrib><creatorcontrib>LA VINCENTE, Sophie F</creatorcontrib><creatorcontrib>NEWCOMBE, David A. L</creatorcontrib><creatorcontrib>ALI, Robert L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><jtitle>Drug and alcohol dependence</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>WHITE, Jason M</au><au>DANZ, Cath</au><au>KNEEBONE, Joanne</au><au>LA VINCENTE, Sophie F</au><au>NEWCOMBE, David A. L</au><au>ALI, Robert L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relationship between LAAM-methadone preference and treatment outcomes</atitle><jtitle>Drug and alcohol dependence</jtitle><addtitle>Drug Alcohol Depend</addtitle><date>2002-05-01</date><risdate>2002</risdate><volume>66</volume><issue>3</issue><spage>295</spage><epage>301</epage><pages>295-301</pages><issn>0376-8716</issn><eissn>1879-0046</eissn><coden>DADEDV</coden><abstract>Studies of relative LAAM-methadone preference have indicated that a significant proportion of patients prefer levo-alpha-acetylmethadol (LAAM). The present study was designed to determine whether this preference is associated with better treatment outcomes. Sixty-two stable methadone patients participated in a randomised crossover clinical trial. They received LAAM (alternate days) and methadone (daily) for 3 months each, followed by a further 6-month period during which they were free to choose between the drugs. LAAM maintenance was associated with a lower rate of heroin use than methadone maintenance based on analysis of morphine concentration in hair and equivalent health outcomes. The majority of subjects showed a preference for LAAM (n=27, 69.2%) rather than methadone (n=12, 30.8%). The main reasons given for the LAAM preference were that it produced less withdrawal (39.3%), fewer side effects (28.5%), less craving for heroin (17.9%), and entailed fewer pick-up days (14.3%). Those who chose LAAM had lower levels of heroin use during LAAM maintenance, significantly better outcomes on two sub-scales of the SF-36 (Vitality and Mental Health), and reported that they felt more normal and that they were 'held' better when on LAAM. For those who chose methadone, there were no differences in outcomes between the LAAM and methadone maintenance periods. Preference for LAAM is associated with treatment outcomes as good or better than those with methadone.</abstract><cop>Shannon</cop><pub>Elsevier Science</pub><pmid>12062464</pmid><doi>10.1016/S0376-8716(02)00007-8</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0376-8716
ispartof Drug and alcohol dependence, 2002-05, Vol.66 (3), p.295-301
issn 0376-8716
1879-0046
language eng
recordid cdi_proquest_miscellaneous_57857503
source Applied Social Sciences Index & Abstracts (ASSIA); ScienceDirect Freedom Collection 2022-2024; ScienceDirect®
subjects Adult
Australia
Biological and medical sciences
Chi-Square Distribution
Cross-Over Studies
Drug addictions
Drug addicts
Female
Heroin
Heroin Dependence - drug therapy
Heroin Dependence - rehabilitation
Humans
Levo-alpha-acetylmethadol
Male
Medical sciences
Methadone
Methadone - therapeutic use
Methadyl Acetate - therapeutic use
Middle Aged
Narcotics - therapeutic use
Outcomes
Patient Satisfaction - statistics & numerical data
Preferences
Statistics, Nonparametric
Toxicology
Treatment
Treatment Outcome
title Relationship between LAAM-methadone preference and treatment outcomes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T06%3A51%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relationship%20between%20LAAM-methadone%20preference%20and%20treatment%20outcomes&rft.jtitle=Drug%20and%20alcohol%20dependence&rft.au=WHITE,%20Jason%20M&rft.date=2002-05-01&rft.volume=66&rft.issue=3&rft.spage=295&rft.epage=301&rft.pages=295-301&rft.issn=0376-8716&rft.eissn=1879-0046&rft.coden=DADEDV&rft_id=info:doi/10.1016/S0376-8716(02)00007-8&rft_dat=%3Cproquest_cross%3E57857503%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c366t-3e795846fe706b368722f3cdd092a16c933b4499712da1a3d6f48849efb7a3763%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=57857503&rft_id=info:pmid/12062464&rfr_iscdi=true